Gene · 5518
Papers1,733
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,733
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism. | Cell Oncol (Dordr) | 2024 | 38888850 | PubTator, text mining | PubMed |
| Case report: A germline CHEK1 c.613 + 2T>C leads to a splicing error in a family with multiple cancer patients. | Front Oncol | 2024 | 38686193 | PubTator, text mining | PubMed |
| PPP2R1A silencing suppresses LUAD progression by sensitizing cells to nelfinavir-induced apoptosis and pyroptosis. | Cancer Cell Int | 2024 | 38654331 | PubTator, text mining | PubMed |
| Structural characterization of methylation-independent PP2A assembly guides alphafold2Multimer prediction of family-wide PP2A complexes. | J Biol Chem | 2024 | 38582449 | PubTator, text mining | PubMed |
| Deciphering cutaneous melanoma prognosis through LDL metabolism: Single-cell transcriptomics analysis via 101 machine learning algorithms. | Exp Dermatol | 2024 | 38570935 | PubTator, text mining | PubMed |
| Structural basis of Integrator-dependent RNA polymerase II termination. | Nature | 2024 | 38570683 | Swiss-Prot, curated | PubMed |
| Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers. | Clin Cancer Res | 2024 | 38536067 | PubTator, text mining | PubMed |
| Retraction: Cancer-Associated PP2A Aα Subunits Induce Functional Haploinsufficiency and Tumorigenicity. | Cancer Res | 2024 | 38486488 | PubTator, text mining | PubMed |
| Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma. | Mod Pathol | 2024 | 38369189 | PubTator, text mining | PubMed |
| Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications. | Int J Mol Sci | 2024 | 38256131 | PubTator, text mining | PubMed |
| Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review). | Oncol Rep | 2024 | 38240090 | PubTator, text mining | PubMed |
| Metastatic Ovarian Serous Adenocarcinoma Clinically Presenting as Inflammatory Breast Cancer. | Case Rep Oncol Med | 2024 | 38239272 | PubTator, text mining | PubMed |
| Altering phosphorylation in cancer through PP2A modifiers. | Cancer Cell Int | 2024 | 38184584 | PubTator, text mining | PubMed |
| B56δ long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan's syndrome mutations. | Proc Natl Acad Sci U S A | 2024 | 38150499 | PubTator, text mining | PubMed |
| Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19. | Nature | 2024 | 38123684 | Swiss-Prot, curated | PubMed |
| Tumor-infiltrating immune cell score as an independent prognostic predictor for endometrial carcinoma: Insights from a comprehensive analysis of the immune landscape. | Cancer Rep (Hoboken) | 2024 | 38017652 | PubTator, text mining | PubMed |
| Detecting and dissecting signaling crosstalk via the multilayer network integration of signaling and regulatory interactions. | Nucleic Acids Res | 2024 | 37953325 | PubTator, text mining | PubMed |
| Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer. | Ann Lab Med | 2024 | 37903652 | PubTator, text mining | PubMed |
| Identification of the prognostic immune subtype in copy-number high endometrial cancer. | J Gynecol Oncol | 2024 | 37857563 | PubTator, text mining | PubMed |
| Molecular Mechanism of PP2A/B55α Phosphatase Inhibition by IER5. | bioRxiv | 2024 | 37693604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5518/papers?page=4